Viewing Study NCT01940900


Ignite Creation Date: 2025-12-26 @ 12:18 PM
Ignite Modification Date: 2026-03-02 @ 3:50 AM
Study NCT ID: NCT01940900
Status: TERMINATED
Last Update Posted: 2024-10-30
First Post: 2013-09-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy
Sponsor: Ophthotech Corporation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Age-Related Macular Degeneration View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Wet AMD View
None choroidal neovascularization View
None Fovista® View
None E10030 View
None Lucentis® View